InvestorsHub Logo
Followers 14
Posts 1420
Boards Moderated 0
Alias Born 06/10/2012

Re: None

Friday, 03/30/2018 1:30:13 PM

Friday, March 30, 2018 1:30:13 PM

Post# of 852
Interesting that ENTEST is part of this analysis; for what it is worth.

Pet Medication Market to Witness Huge Growth by 2023 | Leading Key Players: Zoetis, Merck, Merial, Elanco, Bayer, Boehringer

March 30, 2018 - by info@htfmarketreport.com




HTF MI recently broadcasted a new study in its database that highlights the in-depth market analysis with future prospects of Pet Medication market. The study covers significant data which makes the research document a handy resource for managers, industry executives and other key people get ready-to-access and self analyzed study along with graphs and tables to help understand market trends, drivers and market challenges. Some of the key players mentioned in this research are Zoetis, Merck, Merial, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, Nexvet, Aratana Therapeutics, Kindred Biosciences, Ambrx, Entest Biomedical & Taconic Biosciences.

The research covers the current market size of the China Pet Medication market and its growth rates based on 5 year history data. It also covers various types of segmentation such as by geography [South China, East China, Southwest China, Northeast China, North China, Central China & Northwest China], by product /end user type [Antibiotics, Antifungal & Flea Products], by applications [Cat, Dog, Horse, Fish & Other] in overall market. The in-depth information by segments of Pet Medication market helps monitor performance & make critical decisions for growth and profitability. It provides information on trends and developments, focuses on markets and materials, capacities, technologies, CAPEX cycle and the changing structure of the China Pet Medication Market.



This study also contains company profiling, product picture and specifications, sales, market share and contact information of various international, regional, and local vendors of China Pet Medication Market, some of them are Zoetis, Merck, Merial, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, Nexvet, Aratana Therapeutics, Kindred Biosciences, Ambrx, Entest Biomedical & Taconic Biosciences. The market competition is constantly growing higher with the rise in technological innovation and M&A activities in the industry. Moreover, many local and regional vendors are offering specific application products for varied end-users. The new vendor entrants in the market are finding it hard to compete with